Skip to content

A multinational study to evaluate financial difficulties of patient for breast cancer treatment.

Burden of financial toxicity in Breast Cancer patients treated with curative intend: a multi-national study from low-middle income countries (FIT Study). - FIT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/062071
Enrollment
444
Registered
2024-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Pathologically confirmed new invasive breast cancer cases b. Invasive breast cancer (AJCC 8th edition) c. Received multi-modality treatment with curative intent. d. Patient willing to provide all estimates of expenditure before and after coming to the tertiary hospital, share relevant socio-demographic information and fill or respond to QOL instruments.

Exclusion criteria

Exclusion criteria: a. Unable or unwilling to give written informed consent b. Recurrent or metastatic disease.

Design outcomes

Primary

MeasureTime frame
Estimate of catastrophic health expenditure (CHE)Timepoint: Single interview at the time of radiotherapy treatment planning and review of medical records.

Secondary

MeasureTime frame
a. Proportion of quality indicators adversely affected b. Study impact of FIT on quality of life using EQ5D5L and HADS. c. Objective assessment of FIT using FACIT-COST questionnaire d. Proportion of CHE using OOP expenditure greater than or equal to 40% of total non-food expenditure of household definition e. Proportion of patients facing medical impoverishment (MI) and economic hardship (EC) f. Study disease-related and socio-economic variables associated with FIT g. Study disease-related and socio-economic variables associated with QOLTimepoint: Single interview at the time of radiotherapy treatment planning and review of medical records.

Countries

India

Contacts

Public ContactDr Tabassum Wadasadawala

Tata Memorial Centre

twadasadawala@actrec.gov.in2224177026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026